SafetyLit Journal Details

We are unable to provide photocopies of any the articles and reports abstracted in SafetyLit updates. Where possible, links have been provided to the publisher of the material and contact information for the corresponding author is listed. Please consider asking your library to subscribe to the journals from which these abstracts have been gathered.

To recommend a journal for this list please: Send SafetyLit an Email Message

Med (N Y)

Abbreviation: Med (N Y)

Published by: Cell Press

Publisher Location: New York, NY, USA

Journal Website:
https://www.sciencedirect.com/journal/med/issues

Range of citations in the SafetyLit database: 2021; 2(5) -- 2023; 4(1)

Publication Date Range: 2020 --

Title began with volume (issue): 1(1)

Number of articles from this journal included in the SafetyLit database: 3
(Download all articles from this journal in CSV format.)

pISSN = 2666-6359 | eISSN = 2666-6340
LCCN = 2021229570 | USNLM = 101769215 | OCLC = 1232417760

Find a library that holds this journal: http://worldcat.org/issn/26666359

Journal Language(s): English

Aims and Scope (from publisher): Med is a flagship clinical and translational research monthly journal published by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Chem, and Joule. Our mission is to accelerate translation of bench research to the clinic by providing a communication forum for the exchange of knowledge, fresh ideas, and thought-leadership among translational researchers, clinicians, and Biotech and Pharma scientists as well as other medical research stakeholders. Our goal is to sustainably and ethically improve health globally.

Med publishes rigorously vetted original research and state-of-the-art Review and Perspective articles across the translational and clinical continuum. Our translational research articles are deeply rooted in understanding disease mechanisms, with demonstrable functional impact and broad transformative insights. Our clinical studies cover case reports, first-in-human studies, and large-scale clinical trials, including phase IV, which have the potential to change the course of medical research and improve clinical practice.

Articles in database by volume, issue.